• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初次经皮冠状动脉介入治疗后坚持药物治疗方案的挑战:患者视角。

Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective.

机构信息

Department of Heart Disease, Haukeland University Hospital, Box 1400, 5021 Bergen, Norway.

Department of Heart Disease, Haukeland University Hospital, Box 1400, 5021 Bergen, Norway; Centre of Interprofessional Cooperation within Emergency Care (CICE), Linnaeus University, 351 95 Växjö, Sweden.

出版信息

Int J Nurs Stud. 2018 Dec;88:16-24. doi: 10.1016/j.ijnurstu.2018.07.013. Epub 2018 Jul 26.

DOI:10.1016/j.ijnurstu.2018.07.013
PMID:30165236
Abstract

BACKGROUND

Percutaneous coronary intervention is the most common therapeutic intervention for patients with narrowed coronary arteries due to coronary artery disease. Although it is known that patients with coronary artery disease often do not adhere to their medication regimen, little is known about what patients undergoing percutaneous coronary interventions find challenging in adhering to their medication regimen after hospital discharge.

OBJECTIVES

To explore patients' experiences in adhering to medications following early post-discharge after first-time percutaneous coronary intervention.

DESIGN

An abductive qualitative approach was used to conduct in-depth interviews of patients undergoing first-time percutaneous coronary intervention.

SETTINGS

Participants were recruited from a single tertiary university hospital, which services a large geographical area in western Norway. Patients fulfilling the inclusion criteria were identified through the Norwegian Registry for Invasive Cardiology.

PARTICIPANTS

Participants were patients aged 18 years or older who had their first percutaneous coronary intervention six to nine months earlier, were living at home at the time of study inclusion, and were prescribed dual antiplatelet therapy. Patients who were cognitively impaired, had previously undergone cardiac surgery, and/or were prescribed anticoagulation therapy with warfarin or novel oral anticoagulants were excluded. Purposeful sampling was used to include patients of different gender, age, and geographic settings. Twenty-two patients (12 men) were interviewed between December 2016 and April 2017.

METHODS

Face-to-face semi-structured interviews were conducted, guided by a set of predetermined open-ended questions to gather patient experiences on factors relating to medication adherence or non-adherence. Transcribed interviews were analysed by qualitative content analysis.

FINDINGS

Patients failed to adhere to their medication regimen for several reasons; intentional and unintentional reasons, multifaceted side effects from heart medications, scepticism towards generic drugs, lack of information regarding seriousness of disease after percutaneous coronary intervention, psychological impact of living with coronary artery disease, and these interacted. There were patients who felt that the medication information they received from physicians and nurses was uninformative and inadequate. Side effects from heart medications were common, ranging from minor ones to more disabling side effects, such as severe muscle and joint pain and fatigue. Patients found well established medication taking routines and aids to be necessary, and these improved adherence.

CONCLUSION

Patients undergoing first-time percutaneous coronary intervention face multiple, interacting challenges in trying to adhere to prescribed medications following discharge. This study highlights the need for a more structured follow-up care in order to improve medication adherence and to maximise their self-care abilities.

摘要

背景

经皮冠状动脉介入治疗是治疗因冠状动脉疾病导致冠状动脉狭窄的患者最常用的治疗方法。虽然已知患有冠状动脉疾病的患者通常不遵守其药物治疗方案,但对于接受经皮冠状动脉介入治疗后的患者在出院后在遵守药物治疗方案方面遇到的挑战知之甚少。

目的

探讨首次经皮冠状动脉介入治疗后早期出院患者在坚持药物治疗方面的经验。

设计

采用归纳定性方法对首次经皮冠状动脉介入治疗的患者进行深入访谈。

地点

参与者从挪威西部一个大型地理区域的一家单一的三级大学医院招募。通过挪威介入心脏病学登记处确定符合纳入标准的患者。

参与者

参与者为年龄在 18 岁或以上、在研究纳入时居住在自己家中、并接受双联抗血小板治疗的首次经皮冠状动脉介入治疗 6-9 个月后的患者。认知障碍、先前接受过心脏手术和/或接受华法林或新型口服抗凝剂抗凝治疗的患者被排除在外。采用目的性抽样方法纳入不同性别、年龄和地理环境的患者。2016 年 12 月至 2017 年 4 月期间对 22 名患者(12 名男性)进行了访谈。

方法

进行面对面的半结构化访谈,由一组预定的开放式问题引导,以收集与药物依从性或不依从性相关的患者经验。对转录的访谈进行定性内容分析。

结果

患者未能遵守其药物治疗方案有几个原因;有意和无意的原因、心脏药物的多方面副作用、对仿制药的怀疑、经皮冠状动脉介入治疗后对疾病严重性的信息不足、冠心病带来的心理影响,以及这些因素的相互作用。有些患者认为他们从医生和护士那里获得的药物信息没有信息量和不足。心脏药物的副作用很常见,从轻微到更严重的副作用,如严重的肌肉和关节疼痛和疲劳。患者发现建立良好的服药常规和辅助手段是必要的,这些措施可以提高依从性。

结论

首次接受经皮冠状动脉介入治疗的患者在出院后试图坚持服用规定的药物时面临着多种相互作用的挑战。这项研究强调需要更结构化的随访护理,以提高药物依从性并最大限度地提高他们的自我护理能力。

相似文献

1
Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective.初次经皮冠状动脉介入治疗后坚持药物治疗方案的挑战:患者视角。
Int J Nurs Stud. 2018 Dec;88:16-24. doi: 10.1016/j.ijnurstu.2018.07.013. Epub 2018 Jul 26.
2
Impact of left ventricular ejection fraction and medication adherence on major adverse cardiac events during the first year after successful primary percutaneous coronary interventions.成功进行直接经皮冠状动脉介入治疗后第一年,左心室射血分数和药物依从性对主要不良心脏事件的影响。
J Clin Nurs. 2016 Apr;25(7-8):1101-11. doi: 10.1111/jocn.13109. Epub 2015 Dec 27.
3
The experiences of myocardial infarction patients readmitted within six months of primary percutaneous coronary intervention.初次经皮冠状动脉介入治疗后六个月内再次入院的心肌梗死患者的经历。
J Clin Nurs. 2017 Nov;26(21-22):3511-3518. doi: 10.1111/jocn.13715. Epub 2017 Apr 20.
4
Intentional and unintentional non-adherence to medications following an acute coronary syndrome: a longitudinal study.急性冠状动脉综合征后有意和无意的用药不依从性:一项纵向研究。
J Psychosom Res. 2014 May;76(5):430-2. doi: 10.1016/j.jpsychores.2014.02.007. Epub 2014 Feb 26.
5
Perceptions of generic medicines and medication adherence after percutaneous coronary intervention: a prospective multicentre cohort study.经皮冠状动脉介入治疗后对仿制药和药物依从性的认知:一项前瞻性多中心队列研究。
BMJ Open. 2022 Sep 20;12(9):e061689. doi: 10.1136/bmjopen-2022-061689.
6
Temporal trends for secondary prevention measures among patients hospitalized with coronary artery disease.冠心病住院患者二级预防措施的时间趋势。
Am J Med. 2015 Apr;128(4):426.e1-9. doi: 10.1016/j.amjmed.2014.11.013. Epub 2014 Nov 26.
7
Impact of Polypharmacy on Adherence to Evidence-Based Medication in Patients who Underwent Percutaneous Coronary Intervention.多重用药对接受经皮冠状动脉介入治疗患者遵循循证用药的影响。
Curr Vasc Pharmacol. 2016;14(4):388-93. doi: 10.2174/1570161113666151030105805.
8
Patient medication management, understanding and adherence during the transition from hospital to outpatient care - a qualitative longitudinal study in polymorbid patients with type 2 diabetes.患者的药物管理、从住院过渡到门诊护理期间的理解和依从性 - 2 型糖尿病合并多种疾病患者的定性纵向研究。
BMC Health Serv Res. 2024 May 13;24(1):620. doi: 10.1186/s12913-024-10784-9.
9
Patient-centered adherence intervention after acute coronary syndrome hospitalization.急性冠状动脉综合征住院后的以患者为中心的依从性干预。
Circ Cardiovasc Qual Outcomes. 2012 Jul 1;5(4):571-6. doi: 10.1161/CIRCOUTCOMES.111.962290.
10
Medication Adherence In Post Myocardial Infarction Patients.心肌梗死后患者的药物依从性
J Ayub Med Coll Abbottabad. 2018 Oct-Dec;30(4):552-557.

引用本文的文献

1
Medication Beliefs Regarding P2Y12 Inhibitors: An Exploratory Thematic and Semantic Analysis to Better Understand the Key Barriers to Medication Adherence.关于P2Y12抑制剂的用药观念:一项探索性的主题和语义分析,以更好地理解用药依从性的关键障碍。
Cureus. 2025 Jun 13;17(6):e85924. doi: 10.7759/cureus.85924. eCollection 2025 Jun.
2
Perfect health not so perfect after all - a methodological study on patient-reported outcome measures in 2574 patients following percutaneous coronary intervention.完美健康并非如此完美——一项关于2574例经皮冠状动脉介入治疗患者自我报告结局指标的方法学研究
Health Qual Life Outcomes. 2025 Apr 5;23(1):35. doi: 10.1186/s12955-025-02360-4.
3
Moving Forward Despite Obstacles: A Qualitative Study on Healthy Lifestyle Adjustments Among Patients with Coronary Heart Disease After Their First Percutaneous Coronary Intervention.
尽管有障碍仍不断前行:关于冠心病患者首次经皮冠状动脉介入治疗后健康生活方式调整的定性研究
Int J Gen Med. 2025 Mar 15;18:1451-1461. doi: 10.2147/IJGM.S491082. eCollection 2025.
4
Perceived Determinants of Health-Related Behaviors Among Patients with Coronary Heart Disease After Percutaneous Coronary Intervention: A Longitudinal Qualitative Study.经皮冠状动脉介入治疗后冠心病患者健康相关行为的感知决定因素:一项纵向定性研究
Patient Prefer Adherence. 2024 Mar 6;18:591-606. doi: 10.2147/PPA.S452943. eCollection 2024.
5
Role of Brain-Derived Neurotrophic Factor in Anxiety or Depression After Percutaneous Coronary Intervention.脑源性神经营养因子在经皮冠状动脉介入治疗后焦虑或抑郁中的作用。
Mol Neurobiol. 2024 May;61(5):2921-2937. doi: 10.1007/s12035-023-03758-1. Epub 2023 Nov 10.
6
Downregulation of MicroRNA-29-3p Following Percutaneous Coronary Intervention: An Implication of YY1/IRAK1 Pathway in the Post-Vascular Injury Inflammation.经皮冠状动脉介入治疗后MicroRNA-29-3p的下调:YY1/IRAK1通路在血管损伤后炎症中的作用
Acta Cardiol Sin. 2023 Sep;39(5):742-754. doi: 10.6515/ACS.202309_39(5).20230215A.
7
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.接受冠状动脉介入治疗后接受双联抗血小板治疗和三联治疗的患者的出血风险:ADAPTT 回顾性基于人群的队列研究。
Health Technol Assess. 2023 May;27(8):1-257. doi: 10.3310/MNJY9014.
8
The quality of long-term counselling for percutaneous coronary intervention patients: A cross-sectional study.经皮冠状动脉介入治疗患者长期咨询的质量:一项横断面研究。
Nurs Open. 2023 Aug;10(8):5541-5549. doi: 10.1002/nop2.1793. Epub 2023 Apr 28.
9
Perceptions of generic medicines and medication adherence after percutaneous coronary intervention: a prospective multicentre cohort study.经皮冠状动脉介入治疗后对仿制药和药物依从性的认知:一项前瞻性多中心队列研究。
BMJ Open. 2022 Sep 20;12(9):e061689. doi: 10.1136/bmjopen-2022-061689.
10
MicroRNA-136-5p protects cardiomyocytes from coronary microembolization through the inhibition of pyroptosis.微小RNA-136-5p通过抑制细胞焦亡保护心肌细胞免受冠状动脉微栓塞损伤。
Apoptosis. 2022 Apr;27(3-4):206-221. doi: 10.1007/s10495-022-01712-5. Epub 2022 Jan 27.